GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Activation of arcuate nucleus neurons by systemic administration of leptin and growth hormone-releasing peptide-6 in normal and fasted rats.
Luckman. S M SM; Rosenzweig. I I; Dickson. S L SL
Key Findings
- GHRP‑6 triggers c‑Fos activation in arcuate nucleus neurons, indicating stimulation of the growth hormone axis.
- The neuronal activation by GHRP‑6 is dramatically stronger after a 48‑hour fast, suggesting fasting heightens sensitivity.
- Leptin independently activates arcuate neurons in fasted rats but does not modify the GHRP‑6‑induced response, implying separate pathways.
Practical Outcomes
- For biohackers using GHRP‑6 to boost growth hormone, taking it in a fasted state (e.g., before or after a prolonged fast) may enhance its effect. Adding leptin or leptin‑mimicking supplements is unlikely to further increase GHRP‑6’s action, so focus on timing rather than stacking with leptin.
Summary
In rats, the peptide GHRP‑6 turns on brain cells that control growth hormone, and it works a lot better when the animals have been fasting for two days. Leptin (a hormone linked to fat) also activates some of these brain cells, but it does so through a different route and doesn’t change how GHRP‑6 works.
Abstract
Both leptin and growth hormone secretagogues are believed to have stimulatory effects on the hypothalamic growth hormone pulse generator, though whether these are achieved through the same pathway is unknown. Systemic administration of a normally maximal effective dose of the growth hormone secretagogue GHRP-6 to male rats causes the induction of c-Fos protein in the ventromedial aspect of the hypothalamic arcuate nucleus. The effect of the same dose of GHRP-6 is, however, much greater in animals that have been fasted for 48 h, suggesting that in the food-replete rat, arcuate neurons either show reduced sensitivity to endogenous growth hormone secretagogues or they are under the tonic inhibitory influences of other factors. The major populations of arcuate neurons activated by GHRP-6 have been shown to contain neuropeptide Y or growth hormone-releasing factor, while leptin is thought to be inhibitory to neuropeptide Y neurons. Leptin did not alter the response of the rats to GHRP-6. However, it was able by itself to induce c-Fos protein immunoreactivity in the ventral, including the ventrolateral, arcuate nucleus of fasted rats. This is a clear demonstration of the acute activation of arcuate neurons in the rat following systemic leptin injection and suggests that GHRP-6 and leptin act on the growth hormone axis via different pathways.
Study Information
pubmed
1999
1999-08-01T00:00:00.000Z
10.1159/000054463
52
56